Anastasiia Zherniakova

Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma

Bruno Paiva, Anastasiia Zherniakova, Jorge M. Núñez‐Córdoba et al. · Blood Advances · 2023 · 32 citations · Full text

Medicine, Biostatistics, Oncology +13

Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

Luis‐Esteban Tamariz‐Amador, Anna Martina Battaglia, Catarina Maia et al. · Blood Cancer Journal · 2021 · 24 citations · Full text

Medicine, Hematology, Immunology +16

Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow

Laura Notarfranchi, Anastasiia Zherniakova, Marta Lasa et al. · Blood · 2022 · 15 citations

Medicine, Hematology, Oncology +11

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment

Marta Lasa, Carmen González, Laura Notarfranchi et al. · Blood · 2025 · 14 citations · Full text

Medicine, Hematology, Oncology +14

Pericentromeric Non-Coding DNA Transcription Is Associated with Niche Impairment in Patients with Ineffective or Partially Effective Multiple Myeloma Treatment

N. I. Enukashvily, N. Yu. Semenova, Anna V. Chubar et al. · International Journal of Molecular Sciences · 2022 · 12 citations · Full text

Medicine, Cell Biology, Oncology +17